Patents by Inventor Mercedes Cascon

Mercedes Cascon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enzyme inhibitors
    Publication number: 20080033012
    Abstract: Compounds of general formula (I): where A, E, G, X, Y and the bond - - - take various meanings are of use in the preparation of a pharmaceutical formulation, for example in the treatment of a disease in which GSK-3 is involved, including Alzheimer's disease or the non-dependent insulin diabetes mellitus, or hyperproliferative disease such as cancer, displasias or metaplasias of tissue, psoriasis, arteriosclerosis or restenosis.
    Type: Application
    Filed: April 20, 2007
    Publication date: February 7, 2008
    Inventors: Ana Gil, Ana Morera, Maria Perez, Mercedes Cascon, Isabel Diaz, Francisco Moreno Munoz, Francisco Jurado
  • GSK-3 inhibitors
    Publication number: 20050222220
    Abstract: Provided are thiadiazolidine compounds of formula I wherein R1 is an organic group having at least 8 atoms selected from C or O, which is not linked directly to the N through a —C(O)— and comprising at least an aromatic ring, and their pharmaceutical compositions. These compounds are selective GSK-3 inhibitors and have improved bioavailability. They are useful for the treatment of GSK-3 mediated diseases, among others Alzheimer's disease, type II diabetes, depression and brain injury.
    Type: Application
    Filed: April 5, 2005
    Publication date: October 6, 2005
    Applicant: NEUROPHARMA, S.A.
    Inventors: Miguel Padilla, Mercedes Cascon, Isabel Diaz, Ana Gil, Gema del Pliego, Ana Huerta, Maria Puerto
  • Enzyme inhibitors
    Publication number: 20050014803
    Abstract: Compounds of general formula (I): where A, E, G, X, Y and the bond - - - take various meanings are of use in the preparation of a pharmaceutical formulation, for example in the treatment of a disease in which GSK-3 is involved, including Alzheimer's disease or the non-dependent insulin diabetes mellitus, or hyperproliferative disease such as cancer, displasias or metaplasias of tissue, psoriasis, arteriosclerosis or restenosis.
    Type: Application
    Filed: August 12, 2004
    Publication date: January 20, 2005
    Inventors: Ana Martinez, Ana Castro Morera, Maria Martin Perez, Mercedes Cascon, Isabel Diaz, Francisco Moreno Munoz, Francisco Jurado